Conduit Pharmaceuticals I...

NASDAQ: CDT · Real-Time Price · USD
1.62
-0.05 (-2.99%)
At close: Aug 15, 2025, 3:59 PM
1.71
5.56%
After-hours: Aug 15, 2025, 07:24 PM EDT

Conduit Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
554K 4.23M 345.78K 48.55K
Short-Term Investments
369.75M n/a n/a n/a
Long-Term Investments
n/a n/a 136.87M n/a
Other Long-Term Assets
-1.44B 1.49M -136.87M 108.96K
Receivables
489K n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a 300.86K n/a
Total Current Assets
2.71M 5.73M 646.64K 104.16K
Property-Plant & Equipment
303K n/a n/a n/a
Goodwill & Intangibles
1.44B n/a 5K n/a
Total Long-Term Assets
1.48M 1.49M 5K 108.96K
Total Assets
4.19M 7.22M 5K 213.13K
Account Payables
1.43M 215K n/a n/a
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
7.35M 985K 175K n/a
Other Current Liabilities
n/a n/a 3.1M 6K
Total Current Liabilities
10.74M 1.8M 3.99M 2.23M
Long-Term Debt
n/a n/a 1.83M 749K
Other Long-Term Liabilities
138K 5.88M n/a n/a
Total Long-Term Liabilities
245K 5.88M 6.09M 3.71M
Total Liabilities
10.99M 7.68M 10.08M 5.94M
Total Debt
7.46M 985K 2.01M 749K
Common Stock
14K 7K 136.77M 331.00
Retained Earnings
-29.1M -11.3M -10.76M -5.88M
Comprehensive Income
414K 411K 688K -65K
Shareholders Equity
-6.79M -457K -10.08M -5.94M
Total Investments
-1.18M n/a 136.87M n/a